Fig. 1From: Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumabGBCA-enhancing volume on T1-weighted MRI significantly decreased (P = 0.005) post-BEVBack to article page